CYTK
Cytokinetics, Incorporated
Stock
$65.62−0.29 (−0.44%)Close Oct 1, 2026
| Total assets (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $1.9B | +57.0% | 21.7% | 28.6% |
| Total assets (Q2 2026) | $1.9B |
|---|---|
| YoY | +57.0% |
| 5-year CAGR | 21.7% |
| 10-year CAGR | 28.6% |
Total assets
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $1.4B | +1.6% |
| 2024 | $1.4B | +70.0% |
| 2023 | $824M | −18.8% |
| 2022 | $1.0B | +20.6% |
| 2021 | $841M | +57.6% |
| 2020 | $534M | +84.2% |
| 2019 | $290M | +37.2% |
| 2018 | $211M | −28.4% |
| 2017 | $295M | +73.3% |
| 2016 | $170M | +47.6% |
| 2015 | $115M | −13.3% |
| 2014 | $133M | +59.8% |
| 2013 | $83M | +7.3% |
| 2012 | $78M | +47.0% |
| 2011 | $53M | −32.3% |
| 2010 | $78M | — |